Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool aims to boost lung cancer trial enrollment

NCT ID NCT05888584

Knowledge-focused Sponsor: Oxford Brookes University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study aims to develop and test a tool that helps lung cancer nurses talk to patients about clinical trials. Only about 8% of lung cancer patients in the UK join trials, and nurses often lack the time or confidence to discuss them. The tool will be tested in four UK hospitals to see if it improves the number and quality of these conversations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Research readiness tool
What this could lead to
If effective, this tool could help more lung cancer patients learn about and join clinical trials, potentially improving their treatment options and outcomes.
What could go wrong
This is an early-stage study testing a tool in a small number of hospitals. It may not work in other settings or significantly change recruitment rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Jul 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Healthcare staff Phase 2: Inclusion Criteria: * Actively involved in the clinical care pathways of lung cancer patients * Working at one of the six participating NHS trusts * Age between 18-65 years of age Exclusion criteria: * Not actively involved in frontline clinical care * Not involved in caring for lung cancer patients for at least 30% of their Patients/carers: Inclusion criteria: * Must have a current diagnosis of lung cancer (any stage) or be the named carer of a person with a lung cancer diagnosis * Under the care of (or caring for) one of the participating NHS Trusts lung cancer teams * Aged 18 or over Exclusion criteria: * Mesothelioma diagnosis or caring for someone with a mesothelioma diagnosis * Unable to provide informed consent Phase 4 Healthcare professionals Inclusion criteria: * Registered nurse with Nursing and Midwifery Council * Actively involved in the clinical care pathways of lung cancer patients * Working at one of the six participating NHS trusts * Age between 18-65 years of age Exclusion criteria: * Not actively involved in frontline clinical care * Not involved in caring for lung cancer patients for at least 30% of their role * Employed as a lung cancer research delivery nurse Patients/carers: Inclusion criteria: * Current diagnosis of lung cancer (any stage) or be the named carer of a person with a lung cancer diagnosis * Aged 18 or over * Consented to (or carer of someone who has consented to) a clinical trial since start of pilot study * Receiving care (or carer for someone receiving care) in one of the four NHS sites piloting the research readiness tool Exclusion criteria: * Mesothelioma diagnosis or caring for someone with a mesothelioma diagnosis * Unable to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer

Contacts and locations

Locations

  • Derby and Burton NHS

    Derby, Derbyshire, United Kingdom

  • Lanarkshire NHS

    Glasgow, United Kingdom

  • Oxford University Hospitals

    Oxford, Oxfordshire, United Kingdom

  • Royal Surrey County Hospital

    Guildford, Surrey, United Kingdom

  • Sheffield Teaching Hospitals NHS

    Sheffield, Yorkshire, United Kingdom

  • Sherwood Forest NHS

    Nottingham, Nottinghamshire, United Kingdom

  • St Bartholomews Hospital NHS

    London, Greater London, United Kingdom

  • The Christie NHS

    Manchester, Greater Manchester, United Kingdom

  • The Royal Marsden NHS

    London, Greater London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.